An Evaluation of 9MW1911 Injection in Healthy Subjects
Status:
Active, not recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, dose-escalating phase I clinical study to evaluate
the safety, tolerability and pharmacokinetics of 9MW1911 injection in healthy subjects.